CRISPR for companion diagnostics in low-resource settings

Q Xu, Q Xu, C Lyon, TY Hu - Lab on a Chip, 2024 - pubs.rsc.org
New point-of-care tests (POCTs), which are especially useful in low-resource settings, are
needed to expand screening capacity for diseases that cause significant mortality …

[HTML][HTML] Advancing CRISPR-Based Solutions for COVID-19 Diagnosis and Therapeutics

R Hadi, A Poddar, S Sonnaila, VSM Bhavaraju… - Cells, 2024 - mdpi.com
Since the onset of the COVID-19 pandemic, a variety of diagnostic approaches, including RT-
qPCR, RAPID, and LFA, have been adopted, with RT-qPCR emerging as the gold standard …

Comprehensive insights into pathogenicity and emerging CRISPR-integrated biosensors for the early detection of breast cancer biomarkers

A Saini, N Dilbaghi, N Yadav - Microchemical Journal, 2025 - Elsevier
Breast cancer is a significant healthcare burden, and leading cause of female mortality
globally. This necessitates for efficient, accurate, and early diagnosis of breast cancer …

The current status and future prospects of CRISPR-based detection of monkeypox virus: A review

Y Chen, R Zhao, X Hu, X Wang - Analytica Chimica Acta, 2024 - Elsevier
Background The current pandemic of 2022 global mpox (formerly known as monkeypox),
caused by infection with monkeypox virus (MPXV), has now reached over 120 countries …

CRISPR in clinical diagnostics: bridging the gap between research and practice

Z Lafi, T Ata, S Asha - Bioanalysis, 2025 - Taylor & Francis
ABSTRACT CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) has
transformed molecular biology through its precise gene-editing capabilities. Beyond its initial …